A Study of Pertuzumab in Combination With Trastuzumab and Chemotherapy in Patients With HER2-Positive Metastatic Gastroesophageal Junction or Gastric Cancer

Update Il y a 5 ans
Reference:

Extract


Inclusion criteria

  • HER2-positive metastatic gastroesophageal junction or gastric cancer

Links